Frontlight ResearchEarly access
Active, not recruitingPhase 2
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms
Key facts
- Who runs it
- Oui Therapeutics, Inc.
- Where
- Tallahassee, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- Phase
- Phase 2
- People taking part
- 40 people, planned
- Started
- 9 Dec 2025
- Ended
- 17 Aug 2026
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- OTX-601 Digital Therapeutic
- OTX-003 Comparator app
- Record updated
- 15 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Posttraumatic stress disorder (PTSD) diagnosis
- Anxiety Sensitivity Index 3 (ASI-3) scores above 24
- PTSD Checklist for DSM-V (PCL-5) scores above 30
- Understands and speaks English
- Access to a smartphone that is connected to the internet
Who cannot take part
- Medical illness that would prevent the completion of interoceptive exposure exercises
- Score of 24 or lower on the ASI-3
- Score of 30 and below on the PCL-5
- No PTSD diagnosis
- Active psychosis
- Acute intoxication during study baseline
- Enrolled in another treatment research study
Where in United States
- Florida State UniversityTallahassee, United States
About the trial
What the trial wants to find out
This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.
The 2 groups in the trial
- OTX-601Treatment being tested
A prescription digital therapeutic designed to overcome existing barriers and deliver evidence based treatment for PTSD
Treatment: OTX-601 Digital Therapeutic
- OTX-003Sham treatment, for comparison
OTX-003 is a smartphone application developed as a comparator to OTX-601 and designed to match its interface while providing no active PTSD treatment.
Treatment: OTX-003 Comparator app
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms in a Randomized Controlled Trial (RCT)
- Record updated
- 15 July 2026